• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    AXIS Appoints Pranav Shroff to Lead Life Sciences in North America

    9/9/24 9:15:00 AM ET
    $AXS
    Property-Casualty Insurers
    Finance
    Get the next $AXS alert in real time by email

    AXIS Capital Holdings Limited ("AXIS Capital" or "AXIS" or the "Company") (NYSE:AXS) today announced that Pranav Shroff has joined the Company as Head of Life Sciences in North America.

    Mr. Shroff will lead the development of a suite of specialty coverages in support of the life sciences industry, with an initial focus on Products Liability, Professional Liability, and Clinical Trials Liability. His responsibilities include executing on the underwriting strategy, cultivating relationships with our distribution partners in this specialty segment, and building a team to support this initiative.

    Bringing extensive underwriting experience and knowledge of life sciences, Mr. Shroff joins AXIS from The Doctors Company Specialty Underwriters where he was Vice President. He also previously worked at Chubb, ACE, and CNA. Mr. Shroff will be based in New York and will report to Michael McKenna, Head of AXIS North America.

    "The launch of our Life Sciences offering under Pranav's direction marks another exciting milestone in the growth story of AXIS North America. This expansion into the niche life sciences industry practice area is a natural progression of our ambitions to be the leading specialty carrier in our chosen markets," commented Mr. McKenna. "Pranav has the experience and leadership to build our underwriting capabilities and develop strong ties in this space with our distribution partners thereby elevating solutions for our customers."

    About AXIS Capital

    AXIS Capital, through its operating subsidiaries, is a global specialty underwriter and provider of insurance and reinsurance solutions. The Company has shareholders' equity of $5.7 billion on June 30, 2024, and locations in Bermuda, the United States, Europe, Singapore and Canada. Its operating subsidiaries have been assigned a financial strength rating of "A+" ("Strong") by Standard & Poor's and "A" ("Excellent") by A.M. Best. For more information about AXIS Capital, visit our website at www.axiscapital.com. Follow AXIS Capital on LinkedIn and X Corp.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240909220383/en/

    Get the next $AXS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AXS

    DatePrice TargetRatingAnalyst
    1/13/2025$93.00Market Perform
    BMO Capital Markets
    12/11/2024$78.00 → $89.00Underweight → Equal Weight
    Wells Fargo
    10/4/2024$118.00Buy
    TD Cowen
    11/13/2023$59.00 → $66.00Mkt Perform → Outperform
    Keefe Bruyette
    9/15/2023$53.00 → $68.00Underperform → Buy
    BofA Securities
    9/8/2023$51.00Sell
    Goldman
    12/19/2022$63.00 → $60.00Outperform → Mkt Perform
    Keefe Bruyette
    12/16/2022$55.00Equal Weight → Underweight
    Wells Fargo
    More analyst ratings